Identification and analysis of three myristylated vaccinia virus late proteins

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5218-5226

  Martin, Karen H ^a   Grosenbach, Douglas W ^a   Franke, Christine A ^a   Hruby, Dennis E ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MONKEY; MYRISTYLATION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DETERMINATION; RABBIT; VACCINIA VIRUS;

EID: 0030910253     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5218-5226.1997     Document Type: Article

References (59)

1. Becker, C. R., J. W. Efcavitch, C. R. Heiner, and N. F. Kaiser. 1985. Use of a reverse phase column for the HPLC purification of synthetic oligonucleotides. J. Chromatogr. 326:293-299.
2. Blasco, R., and B. Moss. 1991. Extracellular vaccinia virus formation and cell-to-cell transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope antigen. J. Virol. 65:5910-5920.
3. Blasco, R., J. R. Sisler, and B. Moss. 1993. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J. Virol. 67:3319-3325.
4. Bonner, W. M., and R. A. Laskey. 1974. A film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels. Eur. J. Biochem. 46:83-91.
5. Bryant, M., and L. Ratner. 1990. Myristylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-527.
6. Buss, J. E., and B. M. Sefton. 1985. Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog. J. Virol. 53:7-12.
7. Child, S. J., and D. E. Hruby. 1992. Evidence for multiple species of vaccinia virus-encoded palmitylated proteins. Virology 191:262-271.
8. Chow, M., J. F. Newman, D. Filman, J. M. Hogle, D. J. Rowlands, and F. Brown. 1987. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature 327:482-486.
9. Chung, T. D., et al. 1990. Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). Virology 179:168-178.
10. src myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4:1834-1842.
11. Davison, A. J., and B. Moss. 1989. Structure of vaccinia virus late promoters. J. Mol. Biol. 210:771-784.
12. v-src: myristylation in a cell-free system. Mol. Cell. Biol. 8:4295-1301.
13. Duronio, R. J., D. A. Rudnick, S. P. Adams, D. A. Towler, and J. I. Gordon. 1991. Analyzing the substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase by co-expressing it with mammalian G protein alpha subunits in Escherichia coli. J. Biol. Chem. 266:10498-10504.
14. Engelstad, M., S. T. Howard, and G. L. Smith. 1992. A constitutively expressed vaccinia virus gene encodes a 42 kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801-810.
15. Englestad, M., and G. L. Smith. 1993. The vaccinia virus 42 kDa envelope protein is required for the envelopment and egress of extracellular virus and virus virulence. Virology 194:627-637.
16. Franke, C. A., E. M. Wilson, and D. E. Hruby. 1990. Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25. J. Virol. 64:5988-5996.
17. Franke, C. A., P. L. Reynolds, and D. E. Hruby. 1989. Fatty acylation of vaccinia virus proteins. J. Virol. 63:4285-4291.
18. Gaidigk-Nitschko, K., M. Ding, M. A. Levy, and M. J. Schlesinger. 1990. Site-directed mutations in the Sindhis virus 6K protein reveal sites for fatty acylation and the underacylated protein affects virus release and virion structure. Virology 175:282-291.
19. gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
20. Goebel, S., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266.
21. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
22. Grosenbach, D. W., D. O. Ulaeto, and D. E. Hruby. 1997. Palmitylation of the vaccinia virus 37-kDa major envelope antigen. J. Biol. Chem. 272:1956-1964.
23. Heuckeroth, R. O., D. A. Towler, S. P. Adams, L. Glaser, and J. I. Gordon. 1988. 11-(Ethylthio)undecanoic acid. A myristic acid anologue of altered hydrophobicity which is functional for peptide N-myristylation with wheat germ and yeast acetyltransferase. J. Biol. Chem. 263:2127-2133.
24. Hiller, G., and K. Weber. 1985. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 55:651-659.
25. Hofman, K., and Stoffel. 1993. TMbase - a data base of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler 347:166.
26. Hopp, T. P., and K. R. Woods. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78:3824-3828.
27. Hruby, D. E., and C. A. Franke. 1993. Viral acylproteins: greasing the wheels of assembly. Trends Microbiol. 1:20-25.
28. Hruby, D. E., L. A. Guarino, and J. R. Kates. 1979. Vaccinia virus replication. I. Requirement for the host cell nucleus. J. Virol. 29:705-715.
29. Johnson, D. R., R. S. Bhatnagar, L. J. Knoll, and J. I. Gordon. 1994. Genetic and biochemical studies of protein N-myristoylation. Annu. Rev. Biochem. 63:869-914.
30. Jones, T. L. Z., W. F. Simonds, J. J. Merendino, M. R. Brann, and A. M. Speigel. 1990. Myristoylation of an inhibitory GTP-binding protein a subunit is essential for its membrane attachment. Proc. Natl. Acad. Sci. USA 87: 568-572.
31. src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82:4625-4628.
32. Krausslich, H. G., C. Holscher, Q. Reuer, J. Harber, and E. Wimmer. 1990. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. J. Virol. 64:2433-2436.
33. Krauzewicz, N., C. H. Streuli, N. Stuart-Smith, M. D. Jones, S. Wallace, and B. E. Griffin. 1990. Myristylated polyomavirus VP2: role in the life cycle of the virus. J. Virol. 64:4414-4420.
34. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
35. Marc, D., G. Masson, M. Girard, and S. van der Werf. 1990. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J. Virol. 64:4099-4107.
36. Martin, K. H., and D. E. Hruby. Unpublished data.
37. Miner, J. N., and D. E. Hruby. 1989. Rifampicin prevents virosome localization of L65, an essential vaccinia virus polypeptide. Virology 170:227-237.
38. Moscufo, N., J. Simons, and M. Chow. 1991. Myristoylation is important at multiple stages in poliovirus assembly. J. Virol. 65:2372-2380.
39. Moss, B. 1996. Poxviridae: the viruses and their replication, p. 2637-2671. In B. N. Field et al. (ed.), Field's virology, vol. 2, 3rd ed. Raven Press, New York, N.Y.
40. Parkinson, J. E., and G. E, Smith. 1994. Vaccinia virus gene A36R encodes a Mr 43-50 K protein on the surface of extracellular enveloped virus. Virology 204:376-390.
41. Payne, L. G. 1978. Polypeptidc composition of extracellular enveloped vaccinia virus. J. Virol. 27:28-37.
42. Payne, L. G. 1979. Identification of the vaccinia virus hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J. Virol. 31:147-155.
43. Que, Q., Y. Li, I. N. Wang, L. C. Lane, W. G. Chancy, and J. L. Van Etten. 1994. Protein glycosylation and myristylation in Chlorella virus PBCV-1 and its antigenic variants. Virology 203:320-327.
44. Ravanello, M. P., and D. E. Hruby. 1994. Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope. J. Gen. Virol. 75:1479-1483.
45. Ravanello, M. P., and D. E. Hruby. 1994. Conditional lethal expression of the vaccinia virus L1R myristylprotein reveals a role in virion assembly. J. Virol. 68:6401-6410.
46. gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. USA 83:7246-7250.
47. Resh, M. 1990. Membrane interactions of pp60v-src: a model for myristylated tyrosine protein kinases. Oncogene 5:1437-1444.
48. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
49. Schmelz, M., B. Sodeik, M. Ericsson, E. J. Wolffe, H. Shida, G. Hiller, and G. Griffiths. 1994. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:130-147.
50. Sodeik, B., R. W. Doms, M. Ericcson, G. Hiller, C. E. Machamer, W. van't Hof, G. van Meer, B. Moss, and G. Griffiths. 1993. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasrnic reticulum and the Golgi stacks. J. Cell Biol. 121:521-541.
51. Stevenson, F. T., S. L. Bursten, C. Fanton, R. M. Locksley, and D. H. Lovett. 1993. The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16kDa N-terminal propiece. Proc. Natl. Acad. Sci. USA 90:7245-7249.
52. Stevenson, F. T., S. L. Bursten, R. M. Locksley, and D. H. Lovett. 1992. Myristyl acylation of the tumor necrosis factor alpha precursor on specific lysine residues. J. Exp. Med. 90:7245-7249.
53. Streuli, C. H., and B. E. Griffin. 1987. Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature 326:619-622:
54. Tooze, J., M. Hollinshead, B. Reis, K. Radsak, and H. Kern. 1993. Progeny vaccinia and human cytomegalovirus particle utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60:163-178.
55. Towler, D. A., S. R. Eubanks, D. S. Towery, S. P. Adams, and L. Glaser. 1987. Amino-terminal processing of proteins by N-myristoylation. J. Biol. Chem. 262:1030-1036.
56. Ulaeto, D., D. Grosenbach, and D. E. Hruby. 1995. The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle. J. Virol. 70:3372-3377.
57. Van Slyke, J. K., and D. E. Hruby. 1990. Posttranslational modification of vaccinia virus proteins. Curr. Top. Microbiol. Immunol. 163:185-206.
58. Wolffe, E. J., S. N. Isaacs, and B. Moss. 1993. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67:4732-4741.
59. Wolffe, E. J., S. Vijaya, and B. Moss. 1995. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 211:53-63.